Healthcare Equipment Leasing MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy Lease TypeBy Equipment ConditionBy Lease Duration
Full title & scope — all 5 axes with their segments
Healthcare Equipment Leasing Market Size, Share & Industry Analysis, By Type (Surgical and Therapy Leasing Equipment, Digital and Electronic Equipment, Storage and Transport Leasing Equipment, Personal and Homecare Leasing Equipment, DME), By Application (Hospitals, Diagnostic Centers, Others), By Lease Type (Operating Lease, Finance Lease, Rental), By Equipment Condition (New Equipment, Refurbished/Pre-owned Equipment), By Lease Duration (Short-term Lease, Long-term Lease), and Regional Forecast, 2026-2034
Full table of contents for the published report, chapter by chapter.

- 01By TypeSurgical and Therapy Leasing Equipment · Digital and Electronic Equipment · Storage and Transport Leasing Equipment
- 02By ApplicationHospitals · Diagnostic Centers · Others
- 03By Lease TypeOperating Lease · Finance Lease · Rental
- 04By Equipment ConditionNew Equipment · Refurbished/Pre-owned Equipment
- 05By Lease DurationShort-term Lease · Long-term Lease
- 06By Region
Market Analysis & Outlook
Healthcare equipment leasing covers the rental and lease financing of medical devices and systems, ranging from surgical and imaging equipment to patient monitors, mobility aids and durable medical equipment, in place of outright purchase. Buyers include hospitals, diagnostic and imaging centers, ambulatory surgical facilities and home healthcare providers that need access to clinical equipment without committing capital to ownership, alongside equipment manufacturers and financial institutions that structure and administer the lease agreements. Contracts span short-term rental arrangements covering surge or temporary capacity needs to multi-year operating and finance leases tied to a facility's longer-term equipment plan.
The global healthcare equipment leasing market stood at USD 58.53 billion in 2025. A forecast-period rate of 6.6% takes it to USD 103.92 billion by 2034, and the study reports every year in between, passing USD 38 billion in 2020, USD 53.68 billion in 2024, USD 62.33 billion in 2026 and USD 81.4 billion in 2030.
On the type axis, growth rates run from 4.83% for Storage and Transport Leasing Equipment up to 9.45% for Digital and Electronic Equipment. Surgical and Therapy Leasing Equipment carries the volume: USD 18.85 billion and 32.21% of revenue in 2025, USD 30.14 billion and 29% in 2034. The lines gaining share are Digital and Electronic Equipment and Personal and Homecare Leasing Equipment. Surgical and Therapy Leasing Equipment, Storage and Transport Leasing Equipment and DME lose share without losing revenue.
The application split puts Hospitals first, at USD 33.95 billion and 58% of revenue in 2025, rising to USD 57.16 billion and 55% in 2034. Diagnostic Centers grows faster at 7.85% against 5.96%, moving from 27% of revenue to 30% by 2034. It cuts the same total as the type axis from a different commercial angle, so revenue does not add across the two.
Geographically, 34.21% of 2025 revenue sits in North America (USD 20.02 billion rising to USD 32.22 billion) ahead of Europe at 26.93% and USD 15.76 billion. Middle East and Africa is smallest, at 6%. Because Asia Pacific take share, the revenue added by 2034 concentrates instead of spreading across all five regions.
The 2025 total is a triangulation of published figures and category proxies, short of a directly sourced total. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, five type lines and five segmentation axes across a fifteen-year window.
Market Size, 2020–2034
USD BillionRevenue in USD Billion. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- The global healthcare equipment leasing market moves from USD 38 billion in 2020 to USD 58.53 billion in 2025 and USD 103.92 billion by 2034, the forecast period compounding at 6.6% a year.
- The largest line by type is Surgical and Therapy Leasing Equipment, worth USD 18.85 billion and 32.21% of revenue in 2025, rising to USD 30.14 billion and 29% by 2034.
- At 9.45%, Digital and Electronic Equipment grows faster than any other type line, moving from USD 12.42 billion and 21.21% of revenue in 2025 to USD 28.06 billion and 27% in 2034.
- Scenario range for 2034 runs from USD 93.53 billion in the bear case to USD 112.23 billion in the bull case, against a base-case USD 103.92 billion, the spread a plan built on this forecast has to absorb.
- North America holds 34.21% of global revenue in 2025 at USD 20.02 billion, the largest of the five regions tracked, and reaches USD 32.22 billion by 2034.
- 68% of North America's base-year revenue comes from the United States alone: USD 13.61 billion in 2025, rising to USD 21.91 billion by 2034, which is why it is that region's worked example.
- Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.
Market Trends
Revenue Share, By by type
Base year 2025Surgical and Therapy Leasing Equipment leads with 32.2% of by type segment revenue.
Share of by type segment revenue, most recent base year.
Three things move over 2026-2034, and they are worth separating: the type mix, the regional balance, and the 6.6% compounding underneath both.
All three are changes in mix, not in direction: nothing contracts, and the movement is in which lines and regions absorb the new revenue.
Digital and Electronic Equipment grows faster than Storage and Transport Leasing Equipment. Digital and Electronic Equipment grows at 9.45% across 2026-2034 against 4.83% for Storage and Transport Leasing Equipment, the widest spread on the type axis. By 2034 the two sit at 27% and 12% of revenue, against 21.21% and 13.93% in 2025. Neither contracts: USD 12.42 billion becomes USD 28.06 billion, USD 8.15 billion becomes USD 12.47 billion. What the spread decides is which of them a supplier's revenue is exposed to.
Growth concentrates in Asia Pacific. Asia Pacific moves from 25.86% of revenue in 2025 to 31% in 2034, worth USD 15.14 billion rising to USD 32.22 billion. Share moves off the others in turn: North America at 34.21% moving to 31%, Europe at 26.93% moving to 25%, Latin America at 7% moving to 7%, Middle East and Africa at 6% moving to 6%, each still growing in revenue terms. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.
The series never breaks trajectory. Fifteen years of revenue run USD 38 billion in 2020, USD 53.68 billion in 2024, USD 58.53 billion in 2025, USD 62.33 billion in 2026, USD 81.4 billion in 2030 and USD 103.92 billion in 2034. There is no discontinuity to time, and 6.6% forecast growth against 9.02% historical means the trend continues and does not turn. That moves the planning question away from timing a turn and onto the type and regional mixes, where the actual movement is.
Market Growth Factors
The fastest line decides the blended rate
Market Drivers
3- 01The fastest line decides the blended rate
9.45% growth in Digital and Electronic Equipment, against 6.6% for the market as a whole, moves it from USD 12.42 billion and 21.21% of revenue in 2025 to USD 28.06 billion and 27% in 2034. Because the spread to Storage and Transport Leasing Equipment at 4.83% is this wide, the headline 6.6% is a weighted result, not a rate any single line achieves. A portfolio weighted away from it tracks below the market even in a market growing everywhere.
- 02North America carries 34.21% of the base and keeps growing
North America is the largest region at USD 20.02 billion in 2025, 34.21% of global revenue, and reaches USD 32.22 billion by 2034 while holding 31%. Europe adds a further 26.93% at USD 15.76 billion, reaching USD 25.98 billion. Between them they hold most of the base and most of the revenue added over the period, so equal-weighting the regions in a plan misstates where the growth is.
- 03A demonstrated trajectory, not a projected turnaround
The historical period compounded at 9.02%; USD 38 billion in 2020, USD 53.68 billion in 2024 and USD 58.53 billion in 2025. The forecast period then runs at 6.6%, ending 2034 at USD 103.92 billion. A forecast extending an observed trend is a different proposition from one proposing a turn, and that is why no ramp is applied: the 6.6% runs evenly across the period.
Growth drivers
| # | Growth driver | Impact | Gross contribution (Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Hospital shift toward capital-light equipment access | High | +14 | High | High | Medium |
| 2 | Expansion of home-based and outpatient care needing flexible equipment deployment | Medium-High | +10.5 | Medium | High | High |
| 3 | Rising diagnostic and imaging procedure volumes lifting leased-equipment utilization | Medium-High | +9 | Medium | Medium | High |
| 4 | Growing adoption of refurbished and short-term leasing in cost-sensitive and emerging markets | Medium | +7 | Low | Medium | Medium |
| 5 | Shorter technology refresh cycles in digital and electronic medical equipment | Medium | +6.5 | Medium | Medium | Medium |
| 6 | Others | Low | +3 | Low | Low | Low |
| Total | +50 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | High financing costs constraining independent lessors in emerging markets | Medium-High | −3 | Medium | Medium | Low |
| 2 | Regulatory and reimbursement uncertainty affecting hospital procurement budgets | Medium | −1.6 | Low | Medium | Medium |
| Total | −4.6 | |||||
Drivers contribute 50 Billion and restraints remove 4.6 Billion, a net 45.4 Billion, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
The 6.6% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the type axis, and where regional growth is concentrated.
Restraining Factors
The bear case and what drives it
Market Restraints
2- 01The bear case and what drives it
A bear case of USD 93.53 billion in 2034, against USD 103.92 billion in the base case, rests on one stated assumption: bear case assumes slower normalization of hospital capital budgets and a continued preference for outright equipment purchase in cost-sensitive regions, holding leasing penetration below the base case. Neither case changes the USD 58.53 billion 2025 base.
- 02Surgical and Therapy Leasing Equipment grows below the market rate
With 32.21% of 2025 revenue (USD 18.85 billion) Surgical and Therapy Leasing Equipment is where most of the market sits, and it grows at only 5.36% against the market's 6.6%. Revenue still reaches USD 30.14 billion by 2034 and share still falls to 29%: a drag on the average, not a decline.
Market Opportunities
Upside case: USD 112.23 billion by 2034
Market Opportunities
2- 01Upside case: USD 112.23 billion by 2034
The upside path assumes bull case assumes faster hospital adoption of capital-light leasing amid tighter capital budgets, plus quicker uptake of refurbished and short-term leasing structures in emerging markets. It ends 2034 at USD 112.23 billion against a USD 103.92 billion base case, off the same USD 58.53 billion base year.
- 02Digital and Electronic Equipment is where share changes hands
Digital and Electronic Equipment grows at 9.45% against 6.6% for the market, adding revenue from USD 12.42 billion in 2025 to USD 28.06 billion in 2034 and taking its share from 21.21% to 27%. It is the place on this axis where share changes hands at scale, so it is where an entrant can take position without displacing the incumbent in Surgical and Therapy Leasing Equipment.
Market Challenges
Concentration on the type axis
Market Challenges
2- 01Concentration on the type axis
USD 18.85 billion of 2025 revenue sits in Surgical and Therapy Leasing Equipment, 32.21% of the total, and it is still 29% at USD 30.14 billion nine years later. No other single change on the type axis moves the total as much as a change in demand for that one line.
- 02North America is largely the United States
Of North America's USD 20.02 billion in 2025, USD 13.61 billion (68%) comes from the United States alone, rising to USD 21.91 billion by 2034. Read as a region it looks diversified; read by weight it is not, and the regional forecast inherits whatever happens in that one market.
Segmentation Analysis
5 axesThe market is divided by type and by application, lease type, equipment condition and lease duration; five axes in all. They are alternative readings of one revenue pool, not parts that sum to it.
All five type lines expand in revenue terms over the forecast period. Share is the dividing line; two take it, the others cede it.
By Type · 5 segments
Digital and Electronic Equipment Outpaces the Axis While Surgical and Therapy Leasing Equipment Holds the Largest Share
- Largest Surgical and Therapy Leasing Equipment · 32.2%
- Fastest Digital and Electronic Equipment · 9.4%
- Moves most Digital and Electronic Equipment · +5.8 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Surgical and Therapy Leasing Equipment | $18.85B | 32.2% | $30.14B | 29%-3.2 | 5.4% |
| Digital and Electronic Equipment | $12.42B | 21.2% | $28.06B | 27%+5.8 | 9.4% |
| Storage and Transport Leasing Equipment | $8.15B | 13.9% | $12.47B | 12%-1.9 | 4.8% |
| Personal and Homecare Leasing Equipment | $7.07B | 12.1% | $14.55B | 14%+1.9 | 8.4% |
| DME | $12.04B | 20.6% | $18.71B | 18%-2.6 | 5% |
Surgical and therapy equipment leads because operating rooms and procedural units rely on it continuously and cannot tolerate downtime, favoring lease access over ownership risk. Digital and electronic equipment is growing fastest as imaging, monitoring and connected diagnostic systems are refreshed on shorter technology cycles than mechanical equipment, pushing providers toward leasing instead of repeated capital purchases. The order does not change: Surgical and Therapy Leasing Equipment is still largest in 2034, and what moves is how much it holds. This is the axis the estimation prices in full, year by year, and the one the regional chapters cut against.
By Application · 3 segments
Diagnostic Centers Outpaces the Axis While Hospitals Holds the Largest Share
- Largest Hospitals · 58%
- Fastest Diagnostic Centers · 7.8%
- Moves most Hospitals · -3 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Hospitals | $33.95B | 58% | $57.16B | 55%-3 | 6% |
| Diagnostic Centers | $15.80B | 27% | $31.18B | 30%+3 | 7.8% |
| Others | $8.78B | 15% | $15.59B | 15% | 6.6% |
Hospitals remain the largest lessees because they run the broadest mix of surgical, monitoring and imaging equipment across departments with continuous utilization. Diagnostic centers are growing fastest as standalone imaging and testing facilities expand outside hospital campuses, and leasing lets them add scanning and monitoring capacity without hospital-scale capital budgets. The order does not change: Hospitals is still largest in 2034, and what moves is how much it holds.
By Lease Type · 3 segments
Operating Lease Holds the Largest Lease type Share and Is Still the Quickest to Grow
- Largest Operating Lease · 52%
- Fastest Operating Lease · 7.3%
- Moves most Finance Lease · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Operating Lease | $30.44B | 52% | $57.16B | 55%+3 | 7.3% |
| Finance Lease | $16.39B | 28% | $24.94B | 24%-4 | 4.8% |
| Rental | $11.71B | 20% | $21.82B | 21%+1 | 7.2% |
Operating leases lead because they keep equipment off a provider's balance sheet and allow upgrades at renewal, which suits equipment that dates quickly. Operating leases are also the fastest-growing structure as hospital systems favor predictable periodic payments and flexible upgrade paths over the ownership commitment a finance lease implies. By 2034 Operating Lease is still ahead, making this a shift in weight, not a change of leader.
By Equipment Condition · 2 segments
Scale in New Equipment and Growth in Refurbished/Pre-owned Equipment Define the Equipment condition Axis
- Largest New Equipment · 74%
- Fastest Refurbished/Pre-owned Equipment · 8.3%
- Moves most New Equipment · -4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| New Equipment | $43.31B | 74% | $72.74B | 70%-4 | 5.9% |
| Refurbished/Pre-owned Equipment | $15.22B | 26% | $31.18B | 30%+4 | 8.3% |
New equipment leases lead because clinical and diagnostic accuracy requirements push providers toward current-generation devices for primary care delivery. Refurbished and pre-owned equipment leasing is growing fastest as cost-conscious providers and expanding markets adopt certified pre-owned devices for secondary or backup capacity, extending equipment access without new-unit pricing. By 2034 New Equipment is still ahead, making this a shift in weight, not a change of leader.
By Lease Duration · 2 segments
Long-term Lease Held the Dominant Share of the Lease duration Segment in 2025
- Largest Long-term Lease · 62%
- Fastest Short-term Lease · 7.8%
- Moves most Short-term Lease · +4 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Short-term Lease | $22.24B | 38% | $43.65B | 42%+4 | 7.8% |
| Long-term Lease | $36.29B | 62% | $60.27B | 58%-4 | 5.8% |
Long-term leases lead because most equipment categories are tied to a facility's ongoing clinical program and are budgeted on multi-year cycles. Short-term leases are growing fastest as providers use them to cover seasonal demand swings, temporary capacity gaps and pilot deployments of new equipment types without a multi-year commitment. Long-term Lease remains the largest line through 2034, so the axis changes in proportion, not in order.
Regional Insights
Regional Revenue Share
Base year 2025
Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The largest region covered — 3.2 points of share move elsewhere by 2034, while revenue still grows 1.6×.
- Rank 1 of 5
- 2025 share 34.2%
- By 2034 31%
- Revenue $20.02B → $32.22B
34.21% of the global healthcare equipment leasing market sits in North America in 2025, worth USD 20.02 billion and reaches USD 32.22 billion by 2034. It is a leading region on this axis, first by revenue throughout the period.
By 2034 the share stands at 31%, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
Within the region the type split tracks the global one; 32.21% of 2025 revenue in Surgical and Therapy Leasing Equipment, fastest growth of 9.45% in Digital and Electronic Equipment. North America is reported axis by axis and country by country in the full study.
United States
Sets the pace for North America at 68% of it, growing 1.6×.
- In region 1 of 2
- Of region 68%
- Of global 23.3%
- Revenue $13.61B → $21.91B
The United States is the largest market within North America, generating USD 13.61 billion in 2025 and projected to reach USD 21.91 billion by 2034. Because it is 68% of the region in the base year, North America's totals move with this one country instead of a spread of them. The region itself runs USD 20.02 billion to USD 32.22 billion over the same period, and this is the market carrying the country-level detail in the full report.
The type pattern in the United States is the global one: 32.21% of 2025 revenue in Surgical and Therapy Leasing Equipment, 29% by 2034, against 9.45% growth in Digital and Electronic Equipment taking it from 21.21% to 27%. Because the country carries 68% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. The United States carries its own type breakdown in the full report.
The Food and Drug Administration oversees medical devices under federal law, and equipment offered through a lease must have cleared the appropriate premarket pathway and carry the labeling that pathway requires. Hospitals and clinics using leased equipment remain subject to accreditation and facility conditions covering safe operation and maintenance, so a lessor is expected to supply devices in compliant, properly serviced condition and to pass along any manufacturer safety or recall notice promptly. Primary registration duties sit with the device manufacturer, but a leasing company effectively guarantees that the equipment it places in a clinical setting continues to meet those federal standards for the life of the lease.
The suppliers tracked in this study (De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare and Siemens Financial Services.) compete in the United States across the type lines above. Two different problems sit on the same axis: holding Surgical and Therapy Leasing Equipment at 32.21% of 2025 revenue, and taking Digital and Electronic Equipment while it grows at 9.45%. Country-level positioning and shares for each of these companies are part of the full report, not of this summary.
Canada
2nd-largest in North America, growing 1.6×.
- In region 2 of 2
- Of region 20%
- Of global 6.8%
- Revenue $4B → $6.44B
6.83% of global revenue is generated in Canada; USD 4 billion in 2025, reaching USD 6.44 billion in 2034, and 20% of North America.
Europe Market Analysis
The 2nd-largest region covered — 1.9 points of share move elsewhere by 2034, while revenue still grows 1.6×.
- Rank 2 of 5
- 2025 share 26.9%
- By 2034 25%
- Revenue $15.76B → $25.98B
USD 15.76 billion of 2025 revenue is generated in Europe, 26.93% of the global healthcare equipment leasing market rising to USD 25.98 billion in 2034. Among the five regions it ranks second by revenue in both years.
25% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
The type mix reported at global level applies here, with Surgical and Therapy Leasing Equipment the largest line at 32.21% of 2025 revenue and Digital and Electronic Equipment the fastest-growing at 9.45%. The full report breaks Europe out along every axis and by country.
Germany
The largest market in Europe, growing 1.6×.
- In region 1 of 3
- Of region 30%
- Of global 8.1%
- Revenue $4.73B → $7.79B
Germany is the largest market within Europe, generating USD 4.73 billion in 2025 and projected to reach USD 7.79 billion by 2034. 30% of the region in the base year makes it the largest market here without making it the region. Regional revenue of USD 15.76 billion in 2025 and USD 25.98 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
Composition here matches the global split: the largest line is Surgical and Therapy Leasing Equipment at 32.21% of 2025 revenue, easing to 29% by 2034, and the fastest is Digital and Electronic Equipment at 9.45%, from 21.21% to 27%. Because the country carries 30% of Europe, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-type revenue for Germany appears on its own in the full report.
The EU Medical Device Regulation sets the classification and conformity marking that equipment placed into German healthcare facilities must carry, and a leasing company sourcing devices for hospitals is expected to place only equipment bearing valid conformity marking appropriate to its risk class. The national Medical Devices Operator Ordinance additionally governs how such equipment is operated once installed, requiring documented maintenance intervals, safety checks and operator training regardless of whether the facility owns or leases the device. A lessor is therefore expected to coordinate service schedules with the operator so that conformity is maintained for the whole term of the lease, not simply at the point of delivery.
In Germany the field is De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare and Siemens Financial Services.. Surgical and Therapy Leasing Equipment, at 32.21% of 2025 revenue, is where the volume sits, and Digital and Electronic Equipment, growing at 9.45%, is where position changes hands over the forecast period. Weighting toward Europe means competing for 26.93% of 2025 global revenue, a base of USD 15.76 billion moving to USD 25.98 billion across the forecast period.
United Kingdom
2nd-largest in Europe, growing 1.7×.
- In region 2 of 3
- Of region 24%
- Of global 6.5%
- Revenue $3.78B → $6.24B
The United Kingdom is sized at USD 3.78 billion in 2025, rising to USD 6.24 billion by 2034; 6.46% of global revenue and 24% of Europe. It is reported separately from Germany across every segmentation axis in the full report.
France
3rd-largest in Europe, growing 1.6×.
- In region 3 of 3
- Of region 18%
- Of global 4.8%
- Revenue $2.84B → $4.68B
4.85% of global revenue is generated in France; USD 2.84 billion in 2025, reaching USD 4.68 billion in 2034, and 18% of Europe.
Asia Pacific Market Analysis
The 3rd-largest region covered, and the one gaining the most — it picks up 5.1 points of share by 2034, while revenue still grows 2.1×.
- Rank 3 of 5
- 2025 share 25.9%
- By 2034 31%
- Revenue $15.14B → $32.22B
USD 15.14 billion of 2025 revenue is generated in Asia Pacific, 25.86% of the global healthcare equipment leasing market rising to USD 32.22 billion in 2034. It is a leading region on this axis, third by revenue throughout the period.
Its share rises to 31% over the forecast period, on growth above the market's own 6.6%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.
Segment composition follows the global pattern: Surgical and Therapy Leasing Equipment largest at 32.21% of 2025 revenue, Digital and Electronic Equipment fastest at 9.45%. Asia Pacific is reported axis by axis and country by country in the full study.
China
The largest market in Asia Pacific, growing 2.1×.
- In region 1 of 3
- Of region 38%
- Of global 9.8%
- Revenue $5.75B → $12.24B
38% of Asia Pacific's base-year revenue comes from China; USD 5.75 billion, rising to USD 12.24 billion by 2034. At 38% of the region in 2025 it leads, but a majority of Asia Pacific's revenue is generated in other markets. The region itself runs USD 15.14 billion to USD 32.22 billion over the same period, and this is the market carrying the country-level detail in the full report.
Composition here matches the global split: the largest line is Surgical and Therapy Leasing Equipment at 32.21% of 2025 revenue, easing to 29% by 2034, and the fastest is Digital and Electronic Equipment at 9.45%, from 21.21% to 27%. Because the country carries 38% of Asia Pacific, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by type for China is reported separately in the full report.
Medical devices supplied into China's healthcare system fall under registration and classification requirements administered by the National Medical Products Administration, and equipment offered on lease must hold a registration certificate matching its assigned risk category before it can be placed with a hospital or clinic. Once installed, operators are required to follow equipment management rules issued by health authorities covering installation acceptance, routine maintenance and periodic safety inspection. A leasing company active in this market typically retains responsibility for keeping registration and inspection records current for the equipment it supplies, since a lapsed certificate or missed inspection can bar continued clinical use regardless of the lease terms in place.
Competition in China runs between the suppliers this study tracks: De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare and Siemens Financial Services.. The commercially relevant division is 32.21% of 2025 revenue in Surgical and Therapy Leasing Equipment, where the volume is, against 9.45% growth in Digital and Electronic Equipment, where share moves. The commercial size of that position is USD 15.14 billion in 2025 and USD 32.22 billion by 2034, 25.86% of the global total in the base year.
Japan
2nd-largest in Asia Pacific, growing 2.1×.
- In region 2 of 3
- Of region 22%
- Of global 5.7%
- Revenue $3.33B → $7.09B
5.69% of global revenue is generated in Japan; USD 3.33 billion in 2025, reaching USD 7.09 billion in 2034, and 22% of Asia Pacific.
India
3rd-largest in Asia Pacific, growing 2.1×.
- In region 3 of 3
- Of region 16%
- Of global 4.1%
- Revenue $2.42B → $5.16B
India is sized at USD 2.42 billion in 2025, rising to USD 5.16 billion by 2034; 4.13% of global revenue and 16% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
Latin America Market Analysis
The 4th-largest region covered, holding its share flat through 2034, while revenue still grows 1.8×.
- Rank 4 of 5
- 2025 share 7%
- By 2034 7%
- Revenue $4.10B → $7.27B
7% of the global healthcare equipment leasing market sits in Latin America in 2025, worth USD 4.1 billion with USD 7.27 billion projected for 2034. Among the five regions it ranks fourth by revenue in both years.
7% of global revenue sits here in 2034, below the 2025 level, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.
Within the region the type split tracks the global one; 32.21% of 2025 revenue in Surgical and Therapy Leasing Equipment, fastest growth of 9.45% in Digital and Electronic Equipment. The full report breaks Latin America out along every axis and by country.
Brazil
The largest market in Latin America, growing 1.8×.
- In region 1 of 2
- Of region 45.1%
- Of global 3.2%
- Revenue $1.85B → $3.27B
Brazil is the largest market within Latin America, generating USD 1.85 billion in 2025 and projected to reach USD 3.27 billion by 2034. 45.1% of the region in the base year makes it the largest market here without making it the region. Set against USD 4.1 billion and USD 7.27 billion for the region, it is why this market, and not a smaller one, is the one reported in full.
Brazil buys along the same lines as the market globally; Surgical and Therapy Leasing Equipment first at 32.21% of 2025 revenue and 29% in 2034, Digital and Electronic Equipment fastest at 9.45% on a share moving from 21.21% to 27%. Since 45.1% of Latin America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-type revenue for Brazil appears on its own in the full report.
ANVISA governs the registration, classification and labeling of medical equipment in Brazil, and any device made available through a lease must carry valid ANVISA registration appropriate to its category along with labeling in Portuguese meeting the agency's requirements. Facilities operating leased equipment are expected to maintain calibration and service records demonstrating that the device continues to meet the conditions under which it was registered. A leasing company supplying hospitals and clinics typically shares responsibility for ensuring installation and ongoing maintenance are documented, since ANVISA inspections can extend to equipment in use regardless of whether the operating facility owns it outright or holds it under a lease agreement.
Competition in Brazil runs between the suppliers this study tracks: De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare and Siemens Financial Services.. Volume sits in Surgical and Therapy Leasing Equipment at 32.21% of 2025 revenue; movement sits in Digital and Electronic Equipment at 9.45% growth. That makes Latin America a 7% share of 2025 global revenue, USD 4.1 billion rising to USD 7.27 billion, for any supplier deciding where to concentrate.
Mexico
2nd-largest in Latin America, growing 1.8×.
- In region 2 of 2
- Of region 28%
- Of global 2%
- Revenue $1.15B → $2.04B
1.96% of global revenue is generated in Mexico; USD 1.15 billion in 2025, reaching USD 2.04 billion in 2034, and 28% of Latin America.
Middle East and Africa Market Analysis
The 5th-largest region covered, holding its share flat through 2034, while revenue still grows 1.8×.
- Rank 5 of 5
- 2025 share 6%
- By 2034 6%
- Revenue $3.51B → $6.24B
In Middle East and Africa, 6% of global revenue puts 2025 at USD 3.51 billion and reaches USD 6.24 billion by 2034. Among the five regions it ranks fifth by revenue in both years.
Its share moves to 6% by 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
Surgical and Therapy Leasing Equipment leads here as it does globally, at 32.21% of 2025 revenue, and Digital and Electronic Equipment again grows fastest at 9.45%. Middle East and Africa is reported axis by axis and country by country in the full study.
Saudi Arabia
The largest market in Middle East and Africa, growing 1.8×.
- In region 1 of 2
- Of region 29.9%
- Of global 1.8%
- Revenue $1.05B → $1.87B
USD 1.05 billion of Middle East and Africa's 2025 revenue is generated in Saudi Arabia, the region's largest market, reaching USD 1.87 billion by 2034. It accounts for 29.9% of regional revenue in the base year, the largest single share without dominating the region outright. Regional revenue of USD 3.51 billion in 2025 and USD 6.24 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.
Composition here matches the global split: the largest line is Surgical and Therapy Leasing Equipment at 32.21% of 2025 revenue, easing to 29% by 2034, and the fastest is Digital and Electronic Equipment at 9.45%, from 21.21% to 27%. Because the country carries 29.9% of Middle East and Africa, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Revenue by type for Saudi Arabia is reported separately in the full report.
The Saudi Food and Drug Authority regulates the marketing authorization, classification and labeling of medical devices in the Kingdom, and equipment placed with a hospital or clinic under a lease must carry valid authorization appropriate to its device category. Operating facilities fall under Ministry of Health rules covering safe use, preventive maintenance and periodic inspection of clinical equipment, obligations that extend to devices whether owned outright or supplied through a lessor. A leasing company active in this market is generally expected to confirm that equipment carries current authorization before placement and to support the operator in meeting ongoing maintenance and inspection obligations for as long as the device remains in clinical use.
In Saudi Arabia the field is De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare and Siemens Financial Services.. Surgical and Therapy Leasing Equipment, at 32.21% of 2025 revenue, is where the volume sits, and Digital and Electronic Equipment, growing at 9.45%, is where position changes hands over the forecast period. Weighting toward Middle East and Africa means competing for 6% of 2025 global revenue, a base of USD 3.51 billion moving to USD 6.24 billion across the forecast period.
South Africa
2nd-largest in Middle East and Africa, growing 1.8×.
- In region 2 of 2
- Of region 17.9%
- Of global 1.1%
- Revenue $0.63B → $1.12B
South Africa is sized at USD 0.63 billion in 2025, rising to USD 1.12 billion by 2034; 1.08% of global revenue and 17.9% of Middle East and Africa. It is reported separately from Saudi Arabia across every segmentation axis in the full report.
Request this sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by type, application, lease type, equipment condition, lease duration, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Scale in Surgical and Therapy Leasing Equipment and Growth in Digital and Electronic Equipment Set the Terms of Competition
The field covered here is De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare and Siemens Financial Services..
The competitive line that matters is the type one, not the geographic one. The largest block of revenue is Surgical and Therapy Leasing Equipment: USD 18.85 billion in 2025 at 32.21% of the total, 29% in 2034. Incumbency there is expensive to challenge. Share moves in Digital and Electronic Equipment, growing 9.45% against 4.83% for Storage and Transport Leasing Equipment. The two rarely sit with the same supplier, and that is the reason a USD 58.53 billion market is not already consolidated.
Scale in equipment-finance balance sheets separates the largest suppliers, since a bigger book lets a lessor absorb slower-paying accounts and offer longer or more flexible terms than a smaller lessor can carry. OEM-affiliated financing arms add captive distribution: a manufacturer's own leasing unit can bundle equipment, service contracts and financing into one agreement, and independent lessors respond by emphasizing multi-brand flexibility and faster approval cycles instead. Regulatory and compliance handling for medical devices, including the calibration and maintenance obligations built into a lease, is a further point of separation. Smaller and regional lessors compete on local service response, contract flexibility and relationships with individual hospital procurement teams, not on balance-sheet size.
Geographic reach is the other axis of competition. North America alone accounts for 34.21% of 2025 revenue, so a supplier absent there is absent from the largest part of the market whatever its position elsewhere; Europe adds a further 26.93%.
Per-company profiles, financials, share and development history are in the full report and not here.
List of Key Healthcare Equipment Leasing Market Companies Profiled
6 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- De Lage Landen International(Netherlands)
- GE Capital(United States)
- National Technology Leasing(United States)
- Oak Leasing(United States)
- Rotech Healthcare(United States)
- Siemens Financial Services.
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 5 axes (Type, Application, Lease Type, Equipment Condition, Lease Duration), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 6 key companies, and the research methodology behind every estimate.
Segmentation
5 axes + regionFull chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.
Table of Contents+−
Chapter 1.Executive Summary
Chapter 2.Premium Insights
Chapter 3.Market Definition
Chapter 4.Research Methodology
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
Chapter 7.Market Trends, Strategy & Dynamics
Chapter 8.Porter's Five Forces
Chapter 9.PESTEL Analysis
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
Chapter 13.Market Cost Analysis
Chapter 14.Market Supply-Side Analysis
Chapter 15.Global Healthcare Equipment Leasing Market Size & Projections, 2020–2034, Revenue (USD Billion)
Chapter 16.Global Healthcare Equipment Leasing Market Overview, By Type, 2020–2034, Revenue (USD Billion)
Chapter 17.Global Healthcare Equipment Leasing Market Overview, By Application, 2020–2034, Revenue (USD Billion)
Chapter 18.Global Healthcare Equipment Leasing Market Overview, By Lease Type, 2020–2034, Revenue (USD Billion)
Chapter 19.Global Healthcare Equipment Leasing Market Overview, By Equipment Condition, 2020–2034, Revenue (USD Billion)
Chapter 20.Global Healthcare Equipment Leasing Market Overview, By Lease Duration, 2020–2034, Revenue (USD Billion)
Chapter 21.Global Healthcare Equipment Leasing Market Size — Segment Comparison
Chapter 22.Global Healthcare Equipment Leasing Geography Overview, 2020–2034, Revenue (USD Billion)
Chapter 23.North America Healthcare Equipment Leasing Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 24.Europe Healthcare Equipment Leasing Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 25.Asia Pacific Healthcare Equipment Leasing Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 26.Latin America Healthcare Equipment Leasing Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 27.Middle East and Africa Healthcare Equipment Leasing Market Deep-Dive, 2020–2034, Revenue (USD Billion)
Chapter 28.Application / Use-Case Analysis
Chapter 29.Vendor Capability Scorecard
Chapter 30.Scenario Forecasts
Chapter 31.Top 10 Key Clients of Top 10 Players
Chapter 32.Top 10 Suppliers
Chapter 33.Competitive Landscape
Chapter 34.Partnerships & M&A
Chapter 35.Key Vendor Analysis
Chapter 36.Marketing Strategy Analysis, Distributors & Traders
Chapter 37.Outlook of the Market
Chapter 38.Concluding Analyst Note
List of Figures+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.
List of Tables+−
Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.
Segmentation Analysis
5 axesBy Type
5- 01Surgical and Therapy Leasing Equipment
- 02Digital and Electronic Equipment
- 03Storage and Transport Leasing Equipment
- 04Personal and Homecare Leasing Equipment
- 05DME
By Application
3- 01Hospitals
- 02Diagnostic Centers
- 03Others
By Lease Type
3- 01Operating Lease
- 02Finance Lease
- 03Rental
By Equipment Condition
2- 01New Equipment
- 02Refurbished/Pre-owned Equipment
By Lease Duration
2- 01Short-term Lease
- 02Long-term Lease
Segment categories shown for scope reference. See the Summary tab for revenue share by By Type. Full segment-by-segment detail across every axis is available in the sample and full report.
Research approach
A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.
The estimate is built upward from the installed base of leased medical equipment across hospitals, diagnostic centers and homecare settings, multiplied by realized lease rates for each equipment category: surgical and therapy systems, imaging and monitoring equipment, and mobility or durable medical equipment units. Utilization rates and replacement-cycle assumptions convert unit counts into annual leased-equipment revenue. This build is checked against disclosed equipment-finance and leasing revenue from named lessors and OEM captive-finance arms; where the unit-and-rate build diverges from what a company's own disclosure implies for its regional book, the unit count or lease-rate assumption feeding the build is corrected, not averaged against the disclosed figure.
The four stages
The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.
What the build rests on, and what checks it
The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.
- Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
- Realised pricing by tier and channel, rather than one blended average applied across the whole market
- Take-up and frequency: how much of the addressable base buys, and how often it repeats
- Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
- Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
- Trade and customs flows, where the product crosses borders in a separately recorded form
Data sources
Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.
- Commercial and product leadership at the companies that supply the market
- Procurement and specification leads at the organisations that buy it
- Distributors, integrators and channel partners, where the market is served indirectly
- Regulatory and standards specialists, where approval governs what can be sold at all
- Company filings, annual reports and investor disclosure
- Government statistics, customs records and regulatory registers
- Trade association output and standards-body publications
- Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Interviews target equipment-leasing program managers, hospital procurement and biomedical engineering leads, OEM captive-finance representatives and independent lessors' regional sales managers, since these roles set lease terms, renewal cycles and utilization thresholds. Sampling weights North America and Western Europe, where leasing penetration and disclosure are deepest, while adding targeted conversations in China, India and the Gulf states to capture procurement patterns in markets where leasing is newer and less documented. Regulatory affairs contacts at hospital networks are also included to confirm how reimbursement and capital-budget cycles shape lease-versus-purchase decisions.
Desk research draws on hospital capital-expenditure disclosures in public health-system financial statements, equipment-finance segment reporting from named OEM captive-finance units, U.S. HCPCS and CMS durable-medical-equipment fee schedules that shape lease-versus-purchase economics, FDA device-registration and 510(k) listings confirming which equipment categories are in active clinical use, and customs trade data under HS heading 9018 and 9019 for cross-border equipment shipments feeding leasing pools. National health-expenditure statistics from Eurostat and the OECD supplement regional demand estimates where company-level disclosure is thin.
Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.
Forecasting
The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.
The forecast rests on continued hospital preference for capital-light equipment access, the pace at which digital and electronic equipment categories are refreshed against shortening technology cycles, and the rate at which home-based and outpatient care shifts leased-equipment demand outside acute settings. Reimbursement policy is treated as a pricing input rather than a fixed constant, since coverage changes alter what providers can recover on leased diagnostic and monitoring equipment. The forecast normalizes for the unusually high leasing demand recorded during the pandemic period so that later years reflect underlying structural adoption instead of a temporary surge.
Triangulation and validation
No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.
Historical output was back-tested against recorded growth in hospital capital-expenditure and equipment-finance disclosures for 2020 through 2024, confirming the bottom-up build reproduces observed trends before it is extended forward. Segment-level shifts, particularly the move toward digital and electronic equipment and away from storage and transport categories, were reviewed against procurement specialists' own account of purchasing patterns. Sensitivities were run on lease-rate assumptions and on the pace of the home-care shift, since these two inputs move the forecast total more than any other single assumption.
Confidence and limitations
Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.
Confidence is firmest for hospital-based surgical and therapy leasing in North America and Europe, where equipment-finance disclosure is regular and lease-rate benchmarks are observable. It is thinner for homecare and diagnostic-center leasing in Asia Pacific, Latin America and the Middle East and Africa, where reporting is less consistent and leasing penetration is still forming. A shift in reimbursement policy for leased diagnostic equipment, or a faster-than-expected move of procedures out of hospitals, are the structural risks most likely to force a revision to this estimate.
Every report purchase includes direct access to the lead analyst for scoping questions on the data, at no extra cost and with no separate booking process.
Request a tailored breakdown by geography, segment, or competitor set beyond what's in the standard report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Healthcare Equipment Leasing Market projected to reach?
USD 103.92 Billion by 2034, CAGR 6.6%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 34.21% of global revenue through 2034.
05Which segment leads the market?
Surgical and Therapy Leasing Equipment is the largest line by type, at 32.21% of revenue in 2025.
06Who are the key companies profiled?
De Lage Landen International, GE Capital, National Technology Leasing, Oak Leasing, Rotech Healthcare, Siemens Financial Services.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.